Sultana Shahana Banu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sultana Shahana Banu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Abul Khair Mohammad Shamsuzzaman
National Institute of Laboratory Medicine and Referral Center, Sher E-Bangla Nagar, Dhaka 1207, Bangladesh
1 shared publication Be-Nazir Ahmed
Communicable Disease Control Unit, Directorate General of Health Services, Mohakhali, Dhaka, Bangladesh
1 shared publication- Be-Nazir Ahmed
Directorate General of Health Services (DGHS), Ministry of Health and Family Welfare (MOHFW), Dhaka, Bangladesh
1 shared publication Rady Kim
Parasitology Department, Centre for Infectious Diseases and Microbiology Laboratory Services (CIDMLS), ICPMR, Westmead Hospital, NSW, Australia
1 shared publicationRogan Lee
Parasitology Department, Centre for Infectious Diseases and Microbiology Laboratory Services (CIDMLS), ICPMR, Westmead Hospital, NSW, Australia Discipline of Medicine, Sydney Medical School, University of Sydney, NSW, Australia
1 shared publication- Rogan Lee
NSW Health Pathology, Centre for Infectious Diseases and Microbiological Services, Westmead, New South Wales, Australia
1 shared publication
Latest Publications
- Open Access
- 1 September 2016
- Published by Elsevier in Parasite Epidemiology and Control
- Vol. 1 (3) , 219-228
Evaluation of recombinant K39 antigen and various promastigote antigens in sero-diagnosis of visceral leishmaniasis in Bangladesh
- 1 September 2016
- Published by Elsevier in Parasite Epidemiology and Control
- Vol. 1 (3) , 219-228
Open AccessEvaluation of recombinant K39 antigen and various promastigote antigens in sero-diagnosis of visceral leishmaniasis in Bangladesh
- 18 May 2016
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 110 (5) , 286-293
Detection ofLeishmania donovaniin peripheral blood of asymptomatic individuals in contact with patients with visceral leishmaniasis
The majority of individuals infected with Leishmania donovani complex remain asymptomatic. They may act as transmission reservoirs for visceral leishmaniasis (VL). We investigated sero-prevalence of L. donovani complex amongst those closely associated with patients with VL and whether these sero-reactive individuals had Leishmania parasites in their peripheral blood. Other risk factors were also investigated. A total of 257 individuals in contact with patients with VL were tested for anti-Leishmania antibodies by rK39 immunochromatographic test (rK39 ICT), ELISA using promastigote antigen (p-ELISA) and indirect fluorescent antibody test (IFAT). Buffy coats of rK39 ICT positive individuals were cultured; sero-reactive buffy coats were tested for Leishmania DNA by ITS1 PCR. DNA obtained from culture was sequenced to confirm Leishmania species. Risk factors were evaluated for each sero-positive sample. The results showed 29.2% (75/257) prevalence by serological tests: 14.4% (37/257) were positive by rK39 ICT, 25.3% (65/257) by p-ELISA, 18.3% (47/257) by IFAT and 10.9% (28/257) by all three serological methods. Ten percent (3/30) of cultures were positive for Leishmania promastigotes. Only 3% (2/74) sero-reactive buffy coats were positive for DNA; sequence analysis revealed L. donovani species. Significant risk factors were age, working as farmers, domestic animals in household and proximity to animal shelters. Asymptomatic family members of patients with VL can carry live L. donovani in peripheral blood and may act as potential reservoirs. BankIt1863680 Leishmania KT921417 (DNA sequences of the ribosomal ITS1 region of L. donovani).
- 18 May 2016
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 110 (5) , 286-293
Detection ofLeishmania donovaniin peripheral blood of asymptomatic individuals in contact with patients with visceral leishmaniasis
The majority of individuals infected with Leishmania donovani complex remain asymptomatic. They may act as transmission reservoirs for visceral leishmaniasis (VL). We investigated sero-prevalence of L. donovani complex amongst those closely associated with patients with VL and whether these sero-reactive individuals had Leishmania parasites in their peripheral blood. Other risk factors were also investigated. A total of 257 individuals in contact with patients with VL were tested for anti-Leishmania antibodies by rK39 immunochromatographic test (rK39 ICT), ELISA using promastigote antigen (p-ELISA) and indirect fluorescent antibody test (IFAT). Buffy coats of rK39 ICT positive individuals were cultured; sero-reactive buffy coats were tested for Leishmania DNA by ITS1 PCR. DNA obtained from culture was sequenced to confirm Leishmania species. Risk factors were evaluated for each sero-positive sample. The results showed 29.2% (75/257) prevalence by serological tests: 14.4% (37/257) were positive by rK39 ICT, 25.3% (65/257) by p-ELISA, 18.3% (47/257) by IFAT and 10.9% (28/257) by all three serological methods. Ten percent (3/30) of cultures were positive for Leishmania promastigotes. Only 3% (2/74) sero-reactive buffy coats were positive for DNA; sequence analysis revealed L. donovani species. Significant risk factors were age, working as farmers, domestic animals in household and proximity to animal shelters. Asymptomatic family members of patients with VL can carry live L. donovani in peripheral blood and may act as potential reservoirs. BankIt1863680 Leishmania KT921417 (DNA sequences of the ribosomal ITS1 region of L. donovani).